GA NCORP

TRIALS & PROVIDERS

Menu

NCORP Trials

A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Status
Closed
Cancer Type
Ovarian Cancer
Trial Phase
Phase III
Eligibility
18 Years and older, Female
Study Type
Treatment
NCD ID
NCT02655016
Protocol IDs
PR-30-5017-C (primary)
NCI-2016-00574
Study Sponsor
Tesaro Inc
NCI Full Details
http://clinicaltrials.gov/show/NCT02655016

Summary

This study aims to assess efficacy of Niraparib (GSK3985771) as maintenance treatment in
participants with Stage III or IV ovarian cancer. Participants must have completed
front-line platinum based regimen with complete response (CR) or partial response (PR).
Data collection for Secondary Outcome measures is ongoing and the approximate duration of
the study will be 7 years.
CALL EMAIL

Copyright © 2015, Georgia NCI Community Oncology Research Program. All Rights Reserved.
Powered by GeorgiaCancerInfo.org
Website Design & Development by Peachtree Solutions.